Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity. | ACS Infect Dis | 2022 | 35766385 | PubTator, text mining | PubMed |
| Genetic characterization of two G8P[8] rotavirus strains isolated in Guangzhou, China, in 2020/21: evidence of genome reassortment. | BMC Infect Dis | 2022 | 35764948 | PubTator, text mining | PubMed |
| Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. | Signal Transduct Target Ther | 2022 | 35764603 | PubTator, text mining | PubMed |
| Ongoing Positive Selection Drives the Evolution of SARS-CoV-2 Genomes. | Genomics Proteomics Bioinformatics | 2022 | 35760317 | PubTator, text mining | PubMed |
| Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity, and possible drug therapeutics. | Immun Inflamm Dis | 2022 | 35759231 | PubTator, text mining | PubMed |
| BRET-Based Self-Cleaving Biosensors for SARS-CoV-2 3CLpro Inhibitor Discovery. | Microbiol Spectr | 2022 | 35758897 | PubTator, text mining | PubMed |
| Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes. | J Virol | 2022 | 35758692 | PubTator, text mining | PubMed |
| Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update. | Virol J | 2022 | 35752810 | PubTator, text mining | PubMed |
| The Spectrum of Spitz Melanocytic Lesions: From Morphologic Diagnosis to Molecular Classification. | Front Oncol | 2022 | 35747831 | PubTator, text mining | PubMed |
| Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity. | Viruses | 2022 | 35746815 | PubTator, text mining | PubMed |
| Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines. | Viruses | 2022 | 35746788 | PubTator, text mining | PubMed |
| Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. | Viruses | 2022 | 35746718 | PubTator, text mining | PubMed |
| Recombination in Coronaviruses, with a Focus on SARS-CoV-2. | Viruses | 2022 | 35746710 | PubTator, text mining | PubMed |
| Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein. | Viruses | 2022 | 35746613 | PubTator, text mining | PubMed |
| Computational Investigations of Traditional Chinese Medicinal Compounds against the Omicron Variant of SARS-CoV-2 to Rescue the Host Immune System. | Pharmaceuticals (Basel) | 2022 | 35745660 | PubTator, text mining | PubMed |
| Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? | Molecules | 2022 | 35744958 | PubTator, text mining | PubMed |
| Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths. | J Pers Med | 2022 | 35743779 | PubTator, text mining | PubMed |
| A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors. | Int J Mol Sci | 2022 | 35742913 | PubTator, text mining | PubMed |
Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins. | Int J Mol Sci | 2022 | 35742840 | PubTator, text mining | PubMed |
| AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2. | Biomolecules | 2022 | 35740872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=48